ARAC-02

N/A

Report date: 2022/12/01 17:18:44

Base Information

Drug NameARAC-02
Drug Alias NameARAC-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulantsPolo like kinase 1 inhibitorsProgrammed death-ligand 1 blockers
TargetsPolo like kinase 1Programmed death-ligand 1
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPdx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPdx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A